| Q40528954 | A simple real-time polymerase chain reaction assay using SYBR Green for hepatitis C virus genotyping. |
| Q43039282 | Acute nosocomial HCV infection detected by NAT of a regular blood donor |
| Q43035983 | Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides |
| Q42654339 | At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C. |
| Q42181529 | Cellular immune response to infection by different genotypes of hepatitis C virus |
| Q43047091 | Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease |
| Q24514512 | Clinical significance of hepatitis C virus genotypes |
| Q45876765 | Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease |
| Q42631724 | Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study |
| Q27473052 | Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. |
| Q27473461 | Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein |
| Q71835022 | Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection |
| Q43037115 | Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997). |
| Q27485782 | Determination of genotypes of hepatitis C virus in Venezuela by restriction fragment length polymorphism |
| Q43048804 | Determination of hepatitis C virus genotype by Pyrosequencing |
| Q43030249 | Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate |
| Q27485741 | Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions |
| Q43031293 | Distribution of HCV genotypes among risk groups in Serbia |
| Q42631714 | Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection |
| Q42982618 | Evaluation of two simplified methods for genotyping hepatitis C virus |
| Q42986748 | Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence |
| Q42978426 | Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells |
| Q42692227 | Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward |
| Q42986809 | GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors |
| Q42251718 | Genotypic analysis of hepatitis C virus in khuzestan province, southwestern iran. |
| Q27485608 | Genotyping of hepatitis C virus isolates from Basque Country, Spain |
| Q42983530 | Genotyping of hepatitis C virus performed by type-specific PCR in comparison to nucleotide sequencing of NS5 and core regions |
| Q30245058 | Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes |
| Q27485672 | Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China |
| Q43047258 | HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile |
| Q27473362 | Hepatitis C Virus Subtyping by a Core-Envelope 1-Based Reverse Transcriptase PCR Assay with Sequencing and Its Use in Determining Subtype Distribution among Danish Patients |
| Q42981870 | Hepatitis C genotypes in Finland determined by RFLP. |
| Q27485752 | Hepatitis C virus detection by single-round PCR specific for the terminal 3' noncoding region |
| Q42980056 | Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia |
| Q43049282 | Hepatitis C virus genotypes in Hungarian and Austrian patients with chronic hepatitis C. |
| Q41398433 | Hepatitis C virus infection in dialysis and renal transplantation |
| Q43767234 | Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive |
| Q42987616 | Hepatitis G virus (GBV-C) infection among Brazilian patients with chronic liver disease and blood donors |
| Q42993893 | Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon |
| Q43993357 | Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection |
| Q36192689 | Molecular methods of hepatitis C genotyping. |
| Q43030170 | Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response |
| Q42995344 | Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection |
| Q33972205 | Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes |
| Q42977195 | Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients |
| Q44329316 | Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin |
| Q42979805 | Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group |
| Q42994181 | Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease |
| Q43037975 | Progression of fibrosis in untreated patients with hepatitis C virus infection |
| Q30657711 | Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. |
| Q43037248 | Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission |
| Q27485722 | Second-generation line probe assay for hepatitis C virus genotyping |
| Q43041131 | Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients |